Area of research
Physiology · Public Health, Environmental and Occupational Health
Research interest
Arne Astrup has previously been Chairman of the State Council for Nutrition, and for international research organisations. Major scientific areas are appetite regulation, treatment of obesity, type 2 diabetes, and cardiovascular disease, and diseases where nutrition and physical activity play a role. He is also interested in bridging nutrition, gastronomy and health, and has written a large number of popular diet books, which have been published in many countries, including the United States, Australia and Germany.
Regular-fat and low-fat dairy foods and cardiovascular diseases: perspectives for future dietary recommendations
Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications
On the pathogenesis of obesity: causal models and missing pieces of the puzzle
Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1
An integrated single cell and spatial transcriptomic map of human white adipose tissue
Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models
The carbohydrate-insulin model: a physiological perspective on the obesity pandemic
A Multidisciplinary Perspective of Ultra-Processed Foods and Associated Food Processing Technologies: A View of the Sustainable Road Ahead
Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based?
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
Differential Mitochondrial Gene Expression in Adipose Tissue Following Weight Loss Induced by Diet or Bariatric Surgery
Dietary Glycaemic Index Labelling: A Global Perspective
Interaction of Diet/Lifestyle Intervention and TCF7L2 Genotype on Glycemic Control and Adiposity among Overweight or Obese Adults: Big Data from Seven Randomized Controlled Trials Worldwide
Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations
Dietary Fibre Consensus from the International Carbohydrate Quality Consortium (ICQC)
No Effect of Dietary Fish Oil Supplementation on the Recruitment of Brown and Brite Adipocytes in Mice or Humans under Thermoneutral Conditions
Quantification of diacylglycerol and triacylglycerol species in human fecal samples by flow injection Fourier transform mass spectrometry
Genome-wide gene-based analyses of weight loss interventions identify a potential role for NKX6.3 in metabolism
Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: A Systematic Review and Updated Meta-Analyses of Prospective Cohort Studies
WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach?
Gestational weight gain outside the Institute of Medicine recommendations and adverse pregnancy outcomes: analysis using individual participant data from randomised trials
Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations
A Multi-omics Approach to Unraveling the Microbiome-Mediated Effects of Arabinoxylan Oligosaccharides in Overweight Humans
A Perspective on the Transition to Plant-Based Diets: a Diet Change May Attenuate Climate Change, but Can It Also Attenuate Obesity and Chronic Disease Risk?
Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial
The Environmental <i>Foodprint</i> of Obesity
Impact of maternal education on response to lifestyle interventions to reduce gestational weight gain: individual participant data meta-analysis
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation
Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi‐centre intervention study after a low‐energy diet in 2500 overweight, individuals with pre‐diabetes (PREVIEW)
A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss